ARKQ ARK Autonomous Technology & Robotics ETF
Profitability Metrics
Valuation Metrics
Growth & Cash Flow
Top 10 Holdings
| Stock Ticker | Weight |
|---|---|
| TSLA | 11.12% |
| SPCX | 9.46% |
| TER | 7.24% |
| NVDA | 6.09% |
| KTOS | 5.07% |
| PLTR | 4.78% |
| RKLB | 4.64% |
| GOOG | 4.64% |
| AMD | 4.45% |
| TSM | 4.02% |
ETF Analysis
Fund Overview
ARK Autonomous Technology & Robotics ETF (ARKQ) currently reports 35 stock positions (subject to change), placing it in the diversified without being diffuse range by holdings breadth. The top line-up is TSLA (11.12%), SPCX (9.46%), TER (7.24%), with TSLA as the largest single weight at 11.12%. Together, the top three holdings account for 27.82%, which suggests a more balanced distribution of weight across the portfolio, reducing single-name sensitivity at the top. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.
Profitability & Capital Efficiency
On a capital return basis, ROIC is 34.64%, WACC is 13.15%, and the economic spread is 21.50%. On balance, ROIC clears WACC by a meaningful margin, suggesting the portfolio's holdings are creating rather than consuming intrinsic value. Supporting metrics show ROE at 19.65% and ROA at 7.69%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.
Valuation
From a pricing standpoint, the portfolio sits at trailing P/E of 48.02, forward P/E of 37.92, PEG of 3.52. A wide spread between trailing and forward P/E implies the market is embedding substantial earnings improvement into current prices. A PEG above 2.5 implies investors are paying well above fair value for the growth embedded in estimates — a setup that typically leaves little room for earnings disappointment. A current ratio of 4.37 across the holding set reflects strong short-term liquidity. In total, the multiple and liquidity readings describe a portfolio where valuation is a secondary risk relative to earnings delivery — the numbers are defensible if estimates hold.
Margins & Cash Generation
Stripping to unit economics, gross margin sits at 44.55%, operating margin at -751.57%, and free cash flow margin at 21.72%. Gross margins are healthy, suggesting solid pricing power across the underlying holdings. At this operating margin level, businesses are generating little to no earnings after overhead — a sign of early-stage or high-investment dynamics. At this FCF margin level, the underlying holdings demonstrate good cash generation relative to the revenue base. Across the three margin layers, the picture is inconsistent — a reminder that aggregate metrics can mask meaningful variation at the individual holding level.
Growth & Forward Outlook
Connecting operational trends with market expectations, TTM revenue growth of 57.06% indicating strong organic momentum at the portfolio level, while the estimated 12-month price change of 44.29%, where consensus targets imply substantial appreciation potential over the next 12 months. At 26.6%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.
Conclusion
Strong BuyThe aggregate picture across capital efficiency, valuation, growth, and cash generation builds a compelling case.
These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.